fbpx

Emerging Respiratory Treatments: Frontiers in Pulmonology

Emerging respiratory medicines and treatments, including robotic navigation and gene-editing nanoparticles, may significantly improve patient outcomes in the future for prevalent pulmonary diseases like lung cancer, cystic fibrosis, and chronic obstructive pulmonary disease.

Latest Available Studies for pulmonologists*

Topic Methodology Country Incentive
Asthma Treatments
Online survey
30-min.
Italy/ United Kingdom
Sign up
or Log in
to see the incentive
Cancer treatment trends
Online survey
20-min.
France/ Germany/ United States
Sign up
or Log in
to see the incentive
Chronic Rhinosinusitis with Nasal Polyps
Online survey
30-min.
France/ Germany/ Italy
Sign up
or Log in
to see the incentive
COPD
Online survey
10-min.
Germany
Sign up
or Log in
to see the incentive
Interstitial Lung Diseases (ILDs)
Online survey
60-min.
United States/
Sign up
or Log in
to see the incentive
NSCLC [Non Small Cell Lung Cancer]
Online survey
10-min.
France/ Germany/ Italy/ Spain
Sign up
or Log in
to see the incentive
Pulmonary Hypertension
Online survey
30min.
United States
Sign up
or Log in
to see the incentive

Discover all the pulmonology studies available for you

*Please note that studies are subject to availability and invites are dependent upon a range of criteria. As such, the studies listed above may not always match the studies available on your dashboard